Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
Polyamine-co-ester-co-ortho ester) polymers, methods of forming active agent-load nanoparticles therefrom, and methods of using the nanoparticles for drug delivery are disclosed. The nanoparticles can be coated with an agent that reduces surface charge, an agent that increases cell-specific targeting, or a combination thereof. Typically, the loaded nanoparticles are less toxic, more efficient at drug delivery, or a combination thereof compared to a control or other transfection reagents.
1. A polymeric formulation for delivery of a nucleic acid comprising a poly(amine-co-ester-co-ortho ester) or poly(amine-co-amide-co-ortho ester) having the following formula:
wherein each occurrence of m is an integer from 1-30,
each occurrence of n, p, and q is independently an integer from 1-20, and
each occurrence oft, u, v, and w is independently an integer from 1-1000,
J and Z are independently O or NR′, wherein R′ is hydrogen, substituted or unsubstituted alkyl, or substituted or unsubstituted aryl,
wherein R 4 is hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, substituted alkoxy, aroxy, substituted aroxy, alkylthio, substituted alkylthio, arylthio, substituted arylthio, amino, substituted amino, substituted polyaryl, C 3 -C 20 cyclic, substituted C 3 -C 20 cyclic, heterocyclic, substituted heterocyclic, aminoacid, poly(ethylene glycol), peptide, or polypeptide group,
wherein the ortho ester has the following formula:
wherein r and s are independently an integer from 1-20,
wherein A is absent or A is a single bond,
wherein R 1 , R 1 ′, R 2 , R 2 ′, R 3 , R 3 ′, R 5 , R 5 ′, R 6 and R 6 ′ groups are independently hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, substituted alkoxy, aroxy, substituted aroxy, alkylthio, substituted alkylthio, arylthio, substituted arylthio, carbonyl, substituted carbonyl, carboxyl, substituted carboxyl, amino, substituted amino, amido, substituted amido, polyaryl, substituted polyaryl, C 3 -C 20 cyclic, substituted C 3 -C 20 cyclic, heterocyclic, substituted heterocyclic, aminoacid, poly(ethylene glycol), peptide, or polypeptide group,
wherein the ortho ester is attached to the rest of the polymer at points d and/or e, and
wherein the arrangements of the units within the polymer are ordered or random.
2. The formulation of claim 1 wherein J and Z are each O.
3. The formulation of claim 1 wherein J and Z are each O, and m is an integer from 1-16.
4. The formulation of claim 1 wherein J and Z are each O, m is an integer from 1-16, and n is an integer from 1-10.
5. The formulation of claim 1 wherein J and Z are each O, m is an integer from 1-16, n is an integer from 1-10, and p and q are the same integer from 1-6.
6. The formulation of claim 1 wherein J and Z are each O, m is an integer from 1-16, n is an integer from 1-10, and R 4 is alkyl.
7. The formulation of claim 1 wherein J and Z are each O, m is an integer from 1-16, n is an integer from 1-10, R 4 is alkyl, or aryl and r and s are the same integer from 1-20.
8. The formulation of claim 1 wherein J and Z are each O, m is an integer from 1-16, n is an integer from 1-10, R 4 is alkyl, r and s are the same integer from 1-20, and R 1 , R 1 ′, R 2 , R 2 ′, R 3 , R 3 ′, R 5 , R 5 ′, R 6 and R 6 ′ are each a hydrogen atom.
9. The formulation of claim 1 wherein m is 14, n is 7, p and q are 2, and R 4 is methyl, r and s are 1, 5, or 9.
10. The formulation of claim 1 wherein the arrangements of the units within the polymer are random.
11. The formulation of claim 1 further comprising an alkylene oxide, selected from the group consisting of polyethylene oxide, polypropylene oxide, and/or polyethylene oxide-co-polypropylene oxide.
12. The formulation of claim 11 having the formula:
wherein m is an integer from 1-30,
n, p, and q are independently an integer from 1-20,
t, u, v, w and x are independently integers from 1-1000, and
J and Z are independently 0 or NR′, wherein R′ is hydrogen, substituted or unsubstituted alkyl, or substituted or unsubstituted aryl.
13. The formulation of claim 12 wherein the arrangements of the units within the polymer are random.
14. The formulation of claim 11 , wherein the polymer has the structure:
wherein m is an integer from 1-30,
n, p and q are independently an integer from 1-20,
t, u, v, w and x are independently integers from 1-1000, and
J and Z are independently O or NR′,
wherein R′ is hydrogen, substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, wherein the weight average molecular weight of the polymer is greater than 1,000 Daltons.
15. The formulation of claim 14 wherein the arrangements of the units within the polymer are random.
16. The formulation of claim 1 comprising molecules to be delivered to a compartment of a cell, wherein the molecule is released at the pH of the compartment.
17. The formulation of claim 16 wherein the molecules and polyorthoester are precipitated together and formed into nanoparticles.
18. A method for delivering molecules to a compartment of a cell, wherein the molecule is released at the pH of the compartment, comprising
(i) providing a poly(amine-co-ester-co-ortho ester) or poly(amine-co-amides-co-orthoester) having the following formula:
wherein each occurrence of m is an integer from 1-30,
each occurrence of n, p, and q, is independently an integer from 1-20,
each occurrence oft, u, v, and w is independently an integer from 1-1000, and
J and Z are independently O or NR′, wherein R′ is hydrogen, substituted or unsubstituted alkyl, or substituted or unsubstituted aryl,
wherein R 4 is hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, substituted alkoxy, aroxy, substituted aroxy, alkylthio, substituted alkylthio, arylthio, substituted arylthio, carbonyl, substituted carbonyl, carboxyl, substituted carboxyl, amino, substituted amino, amido, substituted amido, polyaryl, substituted polyaryl, C 3 -C 20 cyclic, substituted C 3 -C 20 cyclic, heterocyclic, substituted heterocyclic, aminoacid, poly(ethylene glycol), peptide, or polypeptide group,
wherein the ortho ester has the following formula:
wherein r and s are independently an integer from 1-20,
wherein A is absent or A is a single bond,
wherein R 1 , R 1 ′, R 2 , R 2 ′, R 3 , R 3 ′, R 5 , R 5 ′, R 6 and R 6 ′ groups are independently hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, substituted alkoxy, aroxy, substituted aroxy, alkylthio, substituted alkylthio, arylthio, substituted arylthio, carbonyl, substituted carbonyl, carboxyl, substituted carboxyl, amino, substituted amino, amido, substituted amido, polyaryl, substituted polyaryl, C 3 -C 20 cyclic, substituted C 3 -C 20 cyclic, heterocyclic, substituted heterocyclic, aminoacid, poly(ethylene glycol), peptide, or polypeptide group,
wherein the ortho ester is attached to the rest of the polymer at points d and/or e, and
wherein the arrangements of the units within the polymer are ordered or random,
(ii) precipitating molecules to be delivered by mixing the orthoester polymer with the molecule in a solution, and
(iii) forming the precipitate into nanoparticles.
19. The method of claim 18 comprising administering the nanoparticles in an effective amount to an individual or cells of an individual in need thereof.
20. The method of claim 18 wherein the nanoparticles are delivered to tissues having a low pH at which the nucleic acid is released.
21. The method of claim 18 wherein the tissues are cancerous, septic, poorly vascularized, infected, or necrotic.
22. A method of making a polymer, the method comprising,
mixing an enzyme catalyst with monomer units under conditions to form a polymer having the formula:
wherein the monomer units are selected from the group consisting of one or more lactones having the formula
one or more diacids or diesters, having the formula
one or more an amine-diols, triamines, or hydroxy diamines, having the formula
and one or more ortho esters having the formula:
wherein R is (CH 2 ) m ;
wherein R′ is hydrogen or alkyl;
wherein R″ substituted or unsubstituted alkyl, or substituted or unsubstituted aryl;
wherein each Z′ is independently OH or N(R′″) 2 , wherein R′″ is hydrogen, substituted or unsubstituted alkyl, or substituted or unsubstituted aryl;
wherein m is an integer from 1-30;
each occurrence of n, p, and q are independently integers from 1-20;
x is an integer from 1 to 1000,
wherein r and s are independently an integer from 1-20,
wherein A is absent or A is a single bond,
wherein R 1 , R 1 ′, R 2 , R 2 ′, R 3 , R 3 ′, R 5 , R 5 ′, R 6 , and R 6 ′ are independently hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkoxy, substituted alkoxy, aroxy, substituted aroxy, alkylthio, substituted alkylthio, arylthio, substituted arylthio, carbonyl, substituted carbonyl, carboxyl, substituted carboxyl, amino, substituted amino, amido, substituted amido, polyaryl, substituted polyaryl, C 3 -C 20 cyclic, substituted C 3 -C 20 cyclic, heterocyclic, substituted heterocyclic, aminoacid, poly(ethylene glycol), peptide, or polypeptide group,
wherein the ortho ester is attached to the rest of the polymer at points d and/or e, and
wherein the arrangements of the units within the polymer are ordered or random.
23. The method of claim 22 , wherein the enzyme catalyst is a lipase.
24. The method of claim 23 , wherein the lipase is lipase B from Candida antarctica.
25. The method of claim 22 , wherein the feed molar ratios of the ortho ester/diacid or diester/amine diol or triamine or hydroxy diamine/lactone is from about 10:90:100:10 to about 50:50:100:10.
26. The method of claim 22 , wherein the weight average molecular weight of the polymers, as measured by gel permeation chromatography using narrow polydispersity polystyrene standards, greater than 1,000 Daltons.
27. The method of claim 22 , comprising
(i) incubating the monomer units and enzyme catalyst at a temperature from between about 80° C. and about 90° C., at about 1 atm N 2 .
28. The method of claim 27 , further comprising, after step (i),
(ii) incubating the monomer units and enzyme catalyst at a temperature from between about 80° C. and about 90° C., at about 1.6 mm Hg.